Mercaptamine hydrochloride viscous eyedrops for corneal cystine deposits in people aged older than 2 years

Document first published:
Page updated:
Topic:
Publication type:

Mercaptamine hydrochloride eye drops are not recommended to be available as a treatment option through routine commissioning for corneal cystine deposits.

Document

Document

Engagement Report

Engagement Report

  • PDF
  • 37 KB
  • 2 pages

Document

Evidence Review

Evidence Review

  • PDF
  • 498 KB
  • 65 pages

Document

Document

CPAG Summary Report

CPAG Summary Report

  • PDF
  • 76 KB
  • 9 pages